Stockscreener 앱 받기
0.4499
4.63%
0.0199
전일 마감가:
$0.43
열려 있는:
$0.429
하루 거래량:
272.94K
Relative Volume:
0.62
시가총액:
$11.32M
수익:
-
순이익/손실:
$-34.10M
주가수익비율:
-0.304
EPS:
-1.48
순현금흐름:
$-32.20M
1주 성능:
+2.25%
1개월 성능:
-9.66%
6개월 성능:
-25.88%
1년 성능:
-28.02%
1일 변동 폭
$0.42
$0.47
1주일 범위
$0.41
$0.50
52주 변동 폭
$0.384
$1.94
센세이 바이오테라 Stock (SNSE) Company Profile
명칭
Sensei Biotherapeutics Inc
전화
(240) 243-8000
주소
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
SNSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
0.4499 | 11.32M | 0 | -34.10M | -32.20M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
센세이 바이오테라 Stock (SNSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2021-07-01 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-06-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2021-03-01 | 개시 | Citigroup | Buy |
| 2021-03-01 | 개시 | Oppenheimer | Outperform |
| 2021-03-01 | 개시 | Piper Sandler | Overweight |
모두보기
센세이 바이오테라 주식(SNSE)의 최신 뉴스
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference - GlobeNewswire
Sensei Biotherapeutics Q3 2024 Results and Strategic Moves - TipRanks
Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace
Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Sensei Biotherapeutics Inc. (SNSE) Quarterly 10-Q Report - Quartzy
Sensei Bio Cuts 46% of Workforce, Extends Cash Runway to 2026 Amid Restructuring | SNSE Stock News - StockTitan
Sensei Biotherapeutics Inc (SNSE) Quarterly 10-Q Report - Quartz
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewswire
3 US Penny Stocks To Monitor In October 2024 - Yahoo Finance Australia
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.01% - MSN
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Up 6% - Defense World
Sensata Technologies Holding plc (NYSE:ST) Stock Holdings Trimmed by Mutual of America Capital Management LLC - Defense World
SeQuent Scientific hits 52-week high, surges nearly 9% in 20 minutes - Business Upturn
SENS Stock on the Rise: A Promising Investment - The InvestChronicle
Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times
Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY
Sensiva Health names Ben Williamson as Chief Executive Officer - WV News
Recent Insider Activity Could Benefit Sensata Technologies Holding Plc (ST) - Knox Daily
Is Seelos Therapeutics Inc (SEEL) worth investing in despite its undervalued state? - US Post News
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
46,650 Shares in Sensata Technologies Holding plc (NYSE:ST) Purchased by Schwerin Boyle Capital Management Inc. - Defense World
Trend Tracker for (ST) - Stock Traders Daily
Benjamin Edwards Inc. Buys 169 Shares of Standex International Co. (NYSE:SXI) - Defense World
Sensei Biotherapeutics names new financial chief - Investing.com India
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com - Defense World
Sensei Biotherapeutics Appoints New Financial Chief - TipRanks
Are Smart Investors Making the Right Decision? Sensata Technologies Holding Plc (ST) - SETE News
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensei Biotherapeutics names new financial chief By Investing.com - Investing.com South Africa
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Multibagger Alert: Senco Gold Stock Soars 300% Since IPO – Is More Growth on the Horizon? Analysts Weigh In! - Share Price India News
SYSTM Wealth Solutions LLC Lowers Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sensei Biotherapeutics’ SNS-103 shows pH-dependent antitumor efficacy - BioWorld Online
Massachusetts Financial Services Co. MA Sells 444,049 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
There is no doubt that Seelos Therapeutics Inc (SEEL) ticks all the boxes. - SETE News
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? - MSN
ST Stock Sees Surge of Approximately 2.46% in Last Five Days - Knox Daily
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? | Stock Market News - Mint
Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
Seelos Therapeutics Inc (SEEL) Stock: A Comprehensive 52-Week Review - The InvestChronicle
American Century Companies Inc. Cuts Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Seneca Foods (NASDAQ:SENEA) Share Price Crosses Above 200-Day Moving Average of $58.33 - MarketBeat
Texas Permanent School Fund Corp Has $1.97 Million Holdings in StoneX Group Inc. (NASDAQ:SNEX) - Defense World
StoneX Group (NASDAQ:SNEX) Hits New 12-Month High at $84.40 - MarketBeat
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Perhaps timely catching Senseonics Holdings Inc (SENS) would be a good idea - SETE News
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
센세이 바이오테라 (SNSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):